SAGE Therapeutics Inc (SAGE)

NASDAQ
Currency in USD
6.70
+0.10(+1.52%)
Closed·
After Hours
6.90+0.20(+2.99%)
·

SAGE Therapeutics (SAGE) Earnings Dates & Reports

Latest Release
Apr 29, 2025
EPS / Forecast
-1.01 / -0.99
Revenue / Forecast
14.06M / 14.14M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
06/2025--/-0.952--/16.95M----Free Sign Up
03/2025-1.01/-0.9914.06M/14.14M-2.02%-0.57%Free Sign Up
12/2024-1.56/-1.512.81M/14.08M-4%-9.02%Free Sign Up
09/2024-1.53/-1.5411.87M/10.8M+0.65%+9.91%Free Sign Up
06/2024-1.7/-1.648.65M/8.75M-3.66%-1.14%Free Sign Up
03/2024-1.8/-1.657.9M/5.11M-9.09%+54.6%Free Sign Up
12/2023-0.55/-1.2877.97M/60.01M+57.03%+29.93%Free Sign Up
09/2023-3.37/-2.682.72M/4.63M-25.75%-41.25%Free Sign Up
06/2023-2.68/-2.552.47M/2.92M-5.1%-15.41%Free Sign Up
03/2023-2.46/-2.53.3M/2.41M+1.6%+36.93%Free Sign Up

All numbers in USD

SAGE Therapeutics Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of -1.01 missed forecast of -0.99; revenue of $14.06M fell short of $14.14M expectation
  • Net loss reduced to $62.2M from $95.8M in Q4 2024; XERZUVEY shipments up 22% quarter-over-quarter
  • Stock declined 2.19% in aftermarket trading to $7.52; company maintains $424M cash reserves
  • Sage projects becoming cash flow positive with XERZUVEY by end of 2026; expects quarter-over-quarter improvements in 2025
  • CEO emphasizes XERZUVEY's potential as key to 'unlock blockbuster potential in PPD'; focus on expanding prescriber base
Last Updated: 04/29/2025, 05:19 PM
Read Full Transcript

FAQ

What Is SAGE Therapeutics's Earnings Per Share (TTM)?

The SAGE Therapeutics EPS (TTM) is -5.79.

When Is The Next SAGE Therapeutics Earnings Date?

SAGE Therapeutics will release its next earnings report on Aug 05, 2025.

What Is SAGE Therapeutics’s Revenue Forecasts For Upcoming Quarters?

SAGE Therapeutics’s revenue forecast is 16.95M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.